Compositions and methods for treating or preventing atrial fibrillation
US9931333B2 · kind B2 · utility
3Cited by
15References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2016 |
| Grant date | Apr 3, 2018 |
| Priority date | — |
| Expiry date | Oct 25, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods for treating or preventing atrial fibrillation (AF). In particular, the present invention provides administration of muscarinic receptor antagonists (e.g., M2-selective muscarinic receptor blockers), administered alone or in combination with other therapeutic agents (e.g., beta-adrenergic receptor blockers) to treat and/or prevent atrial fibrillation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.